Combined targeting of KRT23 and NCCRP1 as a potential novel therapeutic approach for the treatment of triple-negative breast cancer

BACKGROUND: Breast cancers characterized by triple-negative status tend to be more malignant and have a poorer prognosis. A risk model for predicting breast cancer risk should be developed. METHODS: We obtained gene expression and clinical characteristics data using the Clinical Proteomic Tumor Anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jian, Qian, Weiwei, Huang, Cuiliu, Mai, Cunjun, Lai, Yimei, Lin, Zhiqin, Lai, Guie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638800/
https://www.ncbi.nlm.nih.gov/pubmed/36353580
http://dx.doi.org/10.21037/gs-22-486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638800/
https://www.ncbi.nlm.nih.gov/pubmed/36353580
http://dx.doi.org/10.21037/gs-22-486

Ejemplares similares